Sort
48,018 grants matching “immunotherapy”
An innovative integrated computational framework using gene signatures for patient stratification
$464,640Chao Cheng · Baylor College Of Medicine · R01 · FY2023 · CA
Passive and Active Immunization for Pneumocystis
$464,598Francis Gigliotti · University Of Rochester · R01 · FY2016 · AI
Targeting TERT in Melanoma
$464,587Jessie Villanueva · Wistar Institute · R01 · FY2021 · CA
Two Compartment Models to Improve Brain Tumor Therapy
$464,573Edward A Neuwelt · Oregon Health & Science University · R01 · FY2011 · CA
TLR Agonist Nano-Immune Therapy for Peritoneal Metastases
$464,569Rita Elena Serda · University Of New Mexico Health Scis Ctr · R01 · FY2025 · CA
Modulation of Inflammatory Responses by Helminth Glycans
$464,529Richard D Cummings · Beth Israel Deaconess Medical Center · R01 · FY2016 · AI
Virus-Like Particle Based Antigen Display as Multi-component Anticancer Vaccines
$464,527Xuefei Huang · Michigan State University · R01 · FY2014 · CA
Multi-organ culture and pumping systems for ex vivo models of immunity in hybrid tissue-chips
$464,509Rebecca R Pompano · University Of Virginia · R01 · FY2024 · AI
Mechanistic studies of gut microbiota-mediated immune activation against hepatocellular cancer
$464,474Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2021 · CA
Biomaterials for Targeted Modulation of Conventional Type 1 Dendritic Cells
$464,426Hua Wang · University Of Illinois At Urbana-Champaign · R01 · FY2023 · CA
Induction of Tumor Immunity by Secreted HSP-gp96
$464,423Eckhard R Podack · University Of Miami School Of Medicine · P01 · FY2009 · CA
Laboratory and Clinical studies on T-cells recognizing NSCLC
$464,374James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Discovery of potent human antibodies for prevention of (recurrent) HCV infection
$464,322Mansun Law · Scripps Research Institute, The · R01 · FY2011 · AI
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$464,275William E Gillanders · Washington University · P50 · FY2017 · CA
T cell responses to CD1-restricted lipids in tuberculosis
$464,254David Branch Moody · Brigham And Women'S Hospital · R01 · FY2024 · AI
T cell responses to CD1-restricted lipids in tuberculosis
$464,254David Branch Moody · Brigham And Women'S Hospital · R01 · FY2023 · AI
Modeling immunity with a hybrid lymph node tissue-chip
$464,241Rebecca R Pompano · University Of Virginia · R01 · FY2022 · AI
Targeting autophagy to enhance immune checkpoint inhibition
$464,236Ravi K Amaravadi · Wistar Institute · P50 · FY2024 · CA
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
$464,218Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
A Wholly Protein-based Self-assembly Nanoplatform for TNBC-specific Combination Therapy
$464,182Rihe Liu · Univ Of North Carolina Chapel Hill · R01 · FY2024 · EB
Rational in situ programming of cancer vaccine-responding T-cell clones
$464,178Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
T Cell Homeostasis
$464,177Stephen C Jameson · University Of Minnesota · R01 · FY2022 · AI
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses
$464,175Benjamin George Keselowsky · University Of Florida · R01 · FY2019 · DE
Tissue-Targeted Enzyme for Localized Tryptophan Catabolism to Direct Subcutaneous and Oral Mucosal Inflammatory Responses
$464,175Benjamin George Keselowsky · University Of Florida · R01 · FY2020 · DE
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$464,161Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA